Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode, Hardy Diagnostics Ink US Distribution Agreement for MDx System, Test Menu

NEW YORK ─ Applied BioCode on Monday announced it has entered an exclusive agreement with Hardy Diagnostics for the distribution of Applied BioCode's MDx-3000 System and testing menu for the diagnosis of upper respiratory and gastrointestinal infections, and a suite of analyte specific reagents (ASRs) that high-complexity laboratories can use to develop laboratory-developed tests.

Under the terms of the agreement, Hardy Diagnostics will begin offering the MDx-3000 System and tests as well as ASRs to US hospitals and reference laboratories.

Financial and other terms of the agreement were not disclosed.

Applied BioCode noted it has combined digital barcodes with immuno- and molecular chemistry to develop barcoded magnetic bead (BMB) technology. Micro BMBs are tagged with immunochemistry or molecular probes, allowing the digital barcodes to be easily scanned, the firm said.

The Santa Fe Springs, California-based company has obtained US Food and Drug Administration 510(k) clearances for its 17-plex Respiratory Pathogen Panel (RPP) and 17-plex Gastrointestinal Pathogen Panel (GPP) based on its BioCode MDx-3000 automated system. Both panels are also CE-marked.

Additionally, Applied BioCode has also been granted FDA Emergency Use Authorization for its BioCode SARS-CoV-2 Flu Plus Assay and BioCode SARS-CoV-2 Assay, and has obtained an FDA EUA for pooled COVID-19 testing.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.